Email Updates

Search form

You are here

Early HIV Vaccine Trial Builds on Moderately Successful Predecessor

Include in
Media Coverage

By altering the components of the one vaccine ever to show any efficacy against HIV, researchers have succeeded in prompting participants’ immune systems to develop promising antibody and immune-cell responses, according to research published in the Journal of Clinical Investigation. These findings from an early-stage clinical trial suggest that more advanced research is warranted.

October 7, 2019
POZ